Bäck, Magnus

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal

Coronary Interventions and DiagnosticsAcute Myocardial Infarction Research

Cited by 7,166

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal

Health Promotion and Cardiovascular PreventionClinical practice guidelines implementation

Cited by 6,485

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology

Atherosclerosis and Cardiovascular DiseasesFatty Acid Research and Health

Cited by 1,341

Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study

Larsson, S. C., Bäck, M., Rees, J. M. B., Mason, A. M., & Burgess, S. (2020) · European Heart Journal

Genetic Associations and EpidemiologyCardiovascular Disease and Adiposity

Cited by 436

Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7

Bäck, M., Powell, W. S., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2014) · British Journal of Pharmacology

Eicosanoids and Hypertension PharmacologyFatty Acid Research and Health

Cited by 217

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages

Laguna-Fernandez, A., Checa, A., Carracedo, M., Artiach, G., Petri, M. H., Baumgartner, R., Forteza, M. J., Jiang, X., Andonova, T., Walker, M. E., et al. (2018) · Circulation

Fatty Acid Research and HealthAtherosclerosis and Cardiovascular Diseases

Cited by 141

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability

Petri, M. H., Laguna-Fernández, A., Gonzalez-Diez, M., Paulsson-Berne, G., Hansson, G. K., & Bäck, M. (2015) · Cardiovascular Research

Atherosclerosis and Cardiovascular DiseasesCerebrovascular and Carotid Artery Diseases

Cited by 125

Aspirin‐triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E−/− mice

Petri, M. H., Laguna‐Fernandez, A., Arnardottir, H., Wheelock, C. E., Perretti, M., Hansson, G. K., & Bäck, M. (2017) · British Journal of Pharmacology

Atherosclerosis and Cardiovascular DiseasesFatty Acid Research and Health

Cited by 120

Low salivary resolvin D1 to leukotriene B 4 ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation

Thul, S., Labat, C., Temmar, M., Benetos, A., & Bäck, M. (2017) · European Journal of Preventive Cardiology

Fatty Acid Research and HealthEicosanoids and Hypertension Pharmacology

Cited by 81

Aspirin-triggered 15-epi-lipoxin A4 signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation

Petri, M. H., Laguna-Fernandez, A., Tseng, C.-N., Hedin, U., Perretti, M., & Bäck, M. (2015) · International Journal of Cardiology

Fatty Acid Research and HealthEicosanoids and Hypertension Pharmacology

Cited by 60

Roadmap for alleviating the manifestations of ageing in the cardiovascular system

Liberale, L., Tual-Chalot, S., Sedej, S., Ministrini, S., Georgiopoulos, G., Grunewald, M., Bäck, M., Bochaton-Piallat, M.-L., Boon, R. A., Ramos, G. C., et al. (2025) · Nature Reviews Cardiology

Cardiovascular Health and Disease PreventionTelomeres, Telomerase, and Senescence

Cited by 59

Calcific aortic stenosis: omics-based target discovery and therapy development

Blaser, M. C., Bäck, M., Lüscher, T. F., & Aikawa, E. (2025) · European Heart Journal

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 45

Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial

Sarajlic, P., Artiach, G., Larsson, S. C., & Bäck, M. (2021) · Cardiovascular Drugs and Therapy

Fatty Acid Research and HealthAcute Myocardial Infarction Research

Cited by 19